0 patient enrollment & TES ting svcs. See SOW in phase II trial OC depsipeptide in PT S. (protocol # 01-C-0049)
Ended Purchase Order Awarded Last action
- Contract number
- HHSN2612006MQ612651P
- Awardee
-
Peter Maccallum Cancer Institute UEI JXF6PDKH7UM8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $100,000
Award facts
- Contract value 100% obligated
- $100,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Australia
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN2612006MQ612651P?
HHSN2612006MQ612651P was awarded to Peter Maccallum Cancer Institute by National Cancer Institute (National Institutes of Health) on September 25, 2006.
How much is contract HHSN2612006MQ612651P worth?
The government has obligated $100,000 on HHSN2612006MQ612651P.
Was contract HHSN2612006MQ612651P competed?
The extent of competition for HHSN2612006MQ612651P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award